首页> 外文会议>International Symposium on Ceramics in Medicine >Starch-Based Microparticles as a Novel Strategy for Tissue Engineering Applications
【24h】

Starch-Based Microparticles as a Novel Strategy for Tissue Engineering Applications

机译:基于淀粉的微粒作为组织工程应用的新策略

获取原文

摘要

Current tissue engineering strategies involve the use of scaffold materials with properties specific for the target tissue. When the tissue being treated is bone, properties such as bone bonding behaviour and excellent biological performance are very desirable. Many strategies involve the creation in vitro of a suitable hybrid construct (i.e., comprising a scaffold material and cells). These scaffolds are then inserted into the defect site, thus achieving faster integration and hence, repair. Herein, we describe the synthesis and characterization of starch-based microparticles for bone tissue engineering. This study describes the properties of two types of starch-based microparticles: their bioactivity in vitro (when processed with Bioactive Glass 45S5), the good biological performance and also the ability to be used as controlled release vehicles of bioactive molecules, such as steroids and growth factors.
机译:目前的组织工程策略涉及使用具有特异性靶组织的性质的支架材料。当被治疗的组织是骨骼时,非常理想的骨粘合行为和优异的生物学性能。许多策略涉及在合适的杂合构建体体外创造(即,包括支架材料和细胞)。然后将这些支架插入缺陷部位,从而实现更快的整合,因此修复。在此,我们描述了骨组织工程的淀粉基微粒的合成和表征。本研究描述了两种类型的基于淀粉的微粒的性质:它们的生物活性体外(当用生物活性玻璃45s5加工时),良好的生物学性能以及用作生物活性分子的控制释放载体等能力,例如类固醇和生长因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号